NEURAWELL Trademark

Trademark Overview

On Thursday, June 20, 2019, a trademark application was filed for NEURAWELL with the United States Patent and Trademark Office. The USPTO has given the NEURAWELL trademark a serial number of 88481776. The federal status of this trademark filing is REGISTERED as of Tuesday, March 16, 2021. This trademark is owned by Neurawell Therapeutics, Inc.. The NEURAWELL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological activities, namely, scientific research and design in the field of pharmaceuticals; pharmaceutical drug research and development services for the treatment of major depressive disorders, bipolar depression, and ADHD
neurawell

General Information

Serial Number88481776
Word MarkNEURAWELL
Filing DateThursday, June 20, 2019
Status700 - REGISTERED
Status DateTuesday, March 16, 2021
Registration Number6296029
Registration DateTuesday, March 16, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Pseudo MarkNEURA WELL
Goods and ServicesScientific and technological activities, namely, scientific research and design in the field of pharmaceuticals; pharmaceutical drug research and development services for the treatment of major depressive disorders, bipolar depression, and ADHD

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 1, 2019
Primary Code042
First Use Anywhere DateSunday, March 31, 2019
First Use In Commerce DateSunday, March 31, 2019

Trademark Owner History

Party NameNeurawell Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTiburon, CA 94920
US
Party NameNeurawell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTiburon, CA 94920
US
Party NameNeurawell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTiburon, CA 94920
US

Trademark Events

Event DateEvent Description
Monday, June 24, 2019NEW APPLICATION ENTERED
Monday, July 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2019ASSIGNED TO EXAMINER
Monday, September 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 30, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 30, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 30, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 30, 2020SOU EXTENSION 1 FILED
Wednesday, August 5, 2020SOU EXTENSION 1 GRANTED
Thursday, August 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 29, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 30, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, December 30, 2020USE AMENDMENT FILED
Thursday, January 7, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 10, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 11, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 16, 2021REGISTERED-PRINCIPAL REGISTER
Monday, March 16, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

neurawell scientific research major treatment adhd depressive disorders bipolar services depression